Skip to ContentSkip to Navigation
About us How to find us G.J. (Gerard) te Meerman
University Medical Center Groningen

G.J. te Meerman

Universitair Hoofddocent met pensioen
G.J. te Meerman
E-mail:
g.j.te.meerman umcg.nl

Education

 

Primary school (Cornelis Krusemanschool) from 1952-1958

Grammar school (Vondel Gymnasium Amsterdam) from 1958-1964

Study of electronic engineering at the University Twente 1964-1969 (P1 diploma 1965, P2 1967)

Study of mathematical engineering at the University Twente (P2 diploma 1970, Bsc 1970, MSc 1972) specialization : statistics, diploma work in sequential analysis (BSc and MSc)

Extra curricular study of philosophy, especially philosophy of science

PhD study in psychology of language (not finished) at the University Nijmegen

PhD study in Statistical Genetics at the University of Groningen (Thesis: A logic programming approach to pedigree analysis, degree 1991, cum laude, Promotor: Prof. dr. C.H.C.M. Buys)

since 2000 registered biostatistician VVS

 

employment

1967-1970 student assistant in philosophy to Prof. Dr. E. van der Velde

1969-1970 physics teaching in de final year of the VWO at Twickel College Hengelo (0), to replace the teacher who suddenly died

1969-1975 statistical consultant to the project 'Frequencies of mental retardation in Overijssel'

1968-1970 student assistant for computational social science statistics, statistical software development and application.

1972-1978 assistant professor in philosophy of science at the department of philosophical Anthropology, faculty of psychology and Philosophy University of Nijmegen (prof. dr. S. Strasser) Yearly teaching of a 1.5 semester course in philosophy of science. Research on language acquisition of mentally retarded children.

1978-1980 Associate expert in Science and Technology for development Unesco, regional office for science ad technology in Jakarta, Indonesia

1981-2011 assistant and associate professor in mathematical genetics and bioinformatics at the department of Genetics and the Groningen Bioinformatics Center , University Medical Center Groningen and University of Groningen

2011 retirement

2011 - 2013 researcher Departments of pulmonology and genetics, study of resequencing and cancer

2013-present researcher depratment of genetics. `Statistical consultancy, especially non invasive prenatal diagnostics

PhD supervision : B. Meijer (form recognition of gut flora bacteria), M.A. van der Meulen (statistical genetics) E. van Munster (Separation of sperm cells based on interferometry) I.M. Nolte, (statistical genetics), C de Visser (heritability of Diabetes in the island of Urk), B. Sikkema (Quality control of amniotic fluid culture for prenatal diagnosis) , M.M. de Jong (candidate gene studies in breast and colon cancer, M. Zoodsma (candidate genes in cervical cancer) M.Boon (genetics of Multiple Sclerosis), G.T. Spijker (fine mapping of complex traits),L. Oostenbrug (genetics of IBD), M. Niens (Genetics of Hodgkin Lymphoma) A. Diepstra (Genetics of Hodgkin Lymphoma), A. de Vries (statistical genetics), A.G.P. Crijns (Expresion analysis of ovarian cancer), R.S.N. Fehrmann (expression analysis of Ovarian cancer and meta-analysis of expression arrays)

Industrial consultancies

Ingeny BV Leyden, 1994-1997, Holland Genetics (1994-2000) Algene Biotechnologies, Montreal (1996-1999), Galileo genomics, Montreal (2000-2005),

Elected and appointed offices

1969-1970 member of the university council, university Twente

1970-1971 member of the city council, city of Enschede

1983-1989 member of the university council, university of Groningen

1987-1989 chairman of the scientific staff in the university council

1989-1990 chairman (external) of the faculty council

1990-1995 chairman of the scientific staff in the faculty council

1986-1998 member of the university committee for computing affairs

1986-1997 member and since 1992 chairman of the university review committee for large computer purchases

1996-1999 member and chairman of the university committee for university software licences

1993-2000 member of the national NWO programme committee on massive parallel computing

1992-2000 Board member of the Dutch society for Human genetics (NAV)

1995-2012 treasurer of the Simonsfonds, on behalf of the NAV

2009-2016 Member of the NWO committee Investeringen Groot en Middelgroot

publications

List of publications, as of 24 april 2018

A "late-but-fitter revertant cell" explains the high frequency of revertant mosaicism in epidermolysis bullosa.

van den Akker PC, Pasmooij AMG, Joenje H, Hofstra RMW, Te Meerman GJ, Jonkman MF.

PLoS One. 2018 Feb 22;13(2):e0192994. doi: 10.1371/journal.pone.0192994. eCollection 2018.

Sensitive Monogenic Noninvasive Prenatal Diagnosis by Targeted Haplotyping.

Vermeulen C, Geeven G, de Wit E, Verstegen MJAM, Jansen RPM, van Kranenburg M, de Bruijn E, Pulit SL, Kruisselbrink E, Shahsavari Z, Omrani D, Zeinali F, Najmabadi H, Katsila T, Vrettou C, Patrinos GP, Traeger-Synodinos J, Splinter E, Beekman JM, Kheradmand Kia S, Te Meerman GJ, Ploos van Amstel HK, de Laat W.

Am J Hum Genet. 2017 Sep 7;101(3):326-339. doi: 10.1016/j.ajhg.2017.07.012. Epub 2017 Aug 24.

Lamin A/C-Related Cardiac Disease: Late Onset With a Variable and Mild Phenotype in a Large Cohort of Patients With the Lamin A/C p.(Arg331Gln) Founder Mutation.

Hoorntje ET, Bollen IA, Barge-Schaapveld DQ, van Tienen FH, Te Meerman GJ, Jansweijer JA, van Essen AJ, Volders PG, Constantinescu AA, van den Akker PC, van Spaendonck-Zwarts KY, Oldenburg RA, Marcelis CL, van der Smagt JJ, Hennekam EA, Vink A, Bootsma M, Aten E, Wilde AA, van den Wijngaard A, Broers JL, Jongbloed JD, van der Velden J, van den Berg MP, van Tintelen JP.

Circ Cardiovasc Genet. 2017 Aug;10(4). pii: e001631. doi: 10.1161/CIRCGENETICS.116.001

Novel Algorithms for Improved Sensitivity in Non-Invasive Prenatal Testing.

Johansson LF, de Boer EN, de Weerd HA, van Dijk F, Elferink MG, Schuring-Blom GH, Suijkerbuijk RF, Sinke RJ, Te Meerman GJ, Sijmons RH, Swertz MA, Sikkema-Raddatz B.

Sci Rep. 2017 May 12;7(1):1838. doi: 10.1038/s41598-017-02031-5.

NIPTRIC: an online tool for clinical interpretation of non-invasive prenatal testing (NIPT) results.

Sikkema-Raddatz B, Johansson LF, de Boer EN, Boon EM, Suijkerbuijk RF, Bouman K, Bilardo CM, Swertz MA, Dijkstra M, van Langen IM, Sinke RJ, Te Meerman GJ.


de Visser KL, Landman GW, Kleefstra N, Meyboom-de Jong B, de Visser W, te
Meerman GJ, Bilo HJ. Familial Aggregation between the 14th and 21st Century and
Type 2 Diabetes Risk in an Isolated Dutch Population. PLoS One. 2015 Jul
20;10(7):e0132549. doi: 10.1371/journal.pone.0132549. eCollection 2015. Erratum
in: PLoS One. 2015;10(9):e0137939. Kleefstra, Nanne [added]. PubMed PMID:
26193086; PubMed Central PMCID: PMC4508118.

Fehrmann RS, Karjalainen JM, Krajewska M, Westra HJ, Maloney D, Simeonov A,
Pers TH, Hirschhorn JN, Jansen RC, Schultes EA, van Haagen HH, de Vries EG, te
Meerman GJ, Wijmenga C, van Vugt MA, Franke L. Gene expression analysis
identifies global gene dosage sensitivity in cancer. Nat Genet. 2015
Feb;47(2):115-25. doi: 10.1038/ng.3173. Epub 2015 Jan 12. PubMed PMID: 25581432.


Bosker FJ, Terpstra P, Gladkevich AV, Janneke Dijck-Brouwer DA, te Meerman G,
Nolen WA, Schoevers RA, Meesters Y. Changes in winter depression phenotype
correlate with white blood cell gene expression profiles: a combined metagene and
gene ontology approach. Prog Neuropsychopharmacol Biol Psychiatry. 2015 Apr
3;58:8-14. doi: 10.1016/j.pnpbp.2014.10.015. Epub 2014 Nov 29. PubMed PMID:
25455571.


Sijmons RH, te Meerman GJ, Hofstra RM. Charles Buys (1942-2014). Eur J Hum
Genet. 2014 Dec;22(12):1343-4. doi: 10.1038/ejhg.2014.207. PubMed PMID: 25393683;
PubMed Central PMCID: PMC4231401.

Rozendaal AM, van Essen AJ, te Meerman GJ, Bakker MK, van der Biezen JJ,

Goorhuis-Brouwer SM, Vermeij-Keers C, de Walle HE. Periconceptional folic acid

associated with an increased risk of oral clefts relative to non-folate related

malformations in the Northern Netherlands: a population based case-control study.

Eur J Epidemiol. 2013 Nov;28(11):875-87. doi: 10.1007/s10654-013-9849-0. Epub

2013 Oct 4. PubMed PMID: 24092049.





van Dijk FS, Zillikens MC, Micha D, Riessland M, Marcelis CL, de Die-Smulders

CE, Milbradt J, Franken AA, Harsevoort AJ, Lichtenbelt KD, Pruijs HE,

Rubio-Gozalbo ME, Zwertbroek R, Moutaouakil Y, Egthuijsen J, Hammerschmidt M,

Bijman R, Semeins CM, Bakker AD, Everts V, Klein-Nulend J, Campos-Obando N,

Hofman A, te Meerman GJ, Verkerk AJ, Uitterlinden AG, Maugeri A, Sistermans EA,

Waisfisz Q, Meijers-Heijboer H, Wirth B, Simon ME, Pals G. PLS3 mutations in

X-linked osteoporosis with fractures. N Engl J Med. 2013 Oct 17;369(16):1529-36.

doi: 10.1056/NEJMoa1308223. Epub 2013 Oct 2. PubMed PMID: 24088043.





Alves MM, Sribudiani Y, Brouwer RW, Amiel J, Antiñolo G, Borrego S, Ceccherini

I, Chakravarti A, Fernández RM, Garcia-Barcelo MM, Griseri P, Lyonnet S, Tam PK,

van Ijcken WF, Eggen BJ, te Meerman GJ, Hofstra RM. Contribution of rare and

common variants determine complex diseases-Hirschsprung disease as a model. Dev

Biol. 2013 Oct 1;382(1):320-9. doi: 10.1016/j.ydbio.2013.05.019. Epub 2013 May

23. Review. PubMed PMID: 23707863.





Bosker FJ, Gladkevich AV, Pietersen CY, Kooi KA, Bakker PL, Gerbens F, den

Boer JA, Korf J, te Meerman G. Comparison of brain and blood gene expression in

an animal model of negative symptoms in schizophrenia. Prog Neuropsychopharmacol

Biol Psychiatry. 2012 Aug 7;38(2):142-8. doi: 10.1016/j.pnpbp.2012.03.003. Epub

2012 Mar 15. PubMed PMID: 22763037.





Van Der Werf CS, Wabbersen TD, Hsiao NH, Paredes J, Etchevers HC, Kroisel PM,

Tibboel D, Babarit C, Schreiber RA, Hoffenberg EJ, Vekemans M, Zeder SL,

Ceccherini I, Lyonnet S, Ribeiro AS, Seruca R, Te Meerman GJ, van Ijzendoorn SC,

Shepherd IT, Verheij JB, Hofstra RM. CLMP is required for intestinal development,

and loss-of-function mutations cause congenital short-bowel syndrome.

Gastroenterology. 2012 Mar;142(3):453-462.e3. doi: 10.1053/j.gastro.2011.11.038.

Epub 2011 Dec 7. PubMed PMID: 22155368.









Fu J, Wolfs MG, Deelen P, Westra HJ, Fehrmann RS, Te Meerman GJ, Buurman WA,

Rensen SS, Groen HJ, Weersma RK, van den Berg LH, Veldink J, Ophoff RA, Snieder

H, van Heel D, Jansen RC, Hofker MH, Wijmenga C, Franke L. Unraveling the

regulatory mechanisms underlying tissue-dependent genetic variation of gene

expression. PLoS Genet. 2012 Jan;8(1):e1002431. Epub 2012 Jan 19. PubMed PMID:

22275870; PubMed Central PMCID: PMC3261927.





Werf CS, Wabbersen TD, Hsiao NH, Paredes J, Etchevers HC, Kroisel PM, Tibboel

D, Babarit C, Schreiber RA, Hoffenberg EJ, Vekemans M, Zeder SL, Ceccherini I,

Lyonnet S, Ribeiro AS, Seruca R, Te Meerman GJ, van Ijzendoorn SC, Shepherd IT,

Verheij JB, Hofstra RM. CLMP Is Required for Intestinal Development, and

Loss-of-Function Mutations Cause Congenital Short-Bowel Syndrome.

Gastroenterology. 2011 Dec 7. [Epub ahead of print] PubMed PMID: 22155368.





Fehrmann RS, Jansen RC, Veldink JH, Westra HJ, Arends D, Bonder MJ, Fu J,

Deelen P, Groen HJ, Smolonska A, Weersma RK, Hofstra RM, Buurman WA, Rensen S,

Wolfs MG, Platteel M, Zhernakova A, Elbers CC, Festen EM, Trynka G, Hofker MH,

Saris CG, Ophoff RA, van den Berg LH, van Heel DA, Wijmenga C, Te Meerman GJ,

Franke L. Trans-eQTLs reveal that independent genetic variants associated with a

complex phenotype converge on intermediate genes, with a major role for the HLA.

PLoS Genet. 2011 Aug;7(8):e1002197. Epub 2011 Aug 4. PubMed PMID: 21829388;

PubMed Central PMCID: PMC3150446.





Westra HJ, Jansen RC, Fehrmann RS, te Meerman GJ, van Heel D, Wijmenga C,

Franke L. MixupMapper: correcting sample mix-ups in genome-wide datasets

increases power to detect small genetic effects. Bioinformatics. 2011 Aug

1;27(15):2104-11. Epub 2011 Jun 7. PubMed PMID: 21653519.





Sotoodehnia N, Isaacs A, de Bakker PI, Dörr M, Newton-Cheh C, Nolte IM, van

der Harst P, Müller M, Eijgelsheim M, Alonso A, Hicks AA, Padmanabhan S, Hayward

C, Smith AV, Polasek O, Giovannone S, Fu J, Magnani JW, Marciante KD, Pfeufer A,

Gharib SA, Teumer A, Li M, Bis JC, Rivadeneira F, Aspelund T, Köttgen A, Johnson

T, Rice K, Sie MP, Wang YA, Klopp N, Fuchsberger C, Wild SH, Mateo Leach I,

Estrada K, Völker U, Wright AF, Asselbergs FW, Qu J, Chakravarti A, Sinner MF,

Kors JA, Petersmann A, Harris TB, Soliman EZ, Munroe PB, Psaty BM, Oostra BA,

Cupples LA, Perz S, de Boer RA, Uitterlinden AG, Völzke H, Spector TD, Liu FY,

Boerwinkle E, Dominiczak AF, Rotter JI, van Herpen G, Levy D, Wichmann HE, van

Gilst WH, Witteman JC, Kroemer HK, Kao WH, Heckbert SR, Meitinger T, Hofman A,

Campbell H, Folsom AR, van Veldhuisen DJ, Schwienbacher C, O'Donnell CJ, Volpato

CB, Caulfield MJ, Connell JM, Launer L, Lu X, Franke L, Fehrmann RS, te Meerman

G, Groen HJ, Weersma RK, van den Berg LH, Wijmenga C, Ophoff RA, Navis G, Rudan

I, Snieder H, Wilson JF, Pramstaller PP, Siscovick DS, Wang TJ, Gudnason V, van

Duijn CM, Felix SB, Fishman GI, Jamshidi Y, Stricker BH, Samani NJ, Kääb S,

Arking DE. Common variants in 22 loci are associated with QRS duration and

cardiac ventricular conduction. Nat Genet. 2010 Dec;42(12):1068-76. Epub 2010 Nov

14. PubMed PMID: 21076409.





Gene expression profile, pathways, and transcriptional system regulation in indolent systemic mastocytosis.

Niedoszytko M, Oude Elberink JN, Bruinenberg M, Nedoszytko B, de Monchy JG, te Meerman GJ, Weersma RK, Mulder AB, Jassem E, van Doormaal JJ.Allergy. 2011 Feb;66(2):229-37.



Haplotype sharing test maps genes for familial cardiomyopathies. Van Der Zwaag PA, Van Tintelen JP, Gerbens F, Jongbloed JD, Boven LG, Van Der Smagt JJ, Van Der Roest WP, Van Langen IM, Bikker H, Hauer RN, Van Den Berg MP, Hofstra RM, Te Meerman GJ.

Clin Genet. 2010 May 22. doi: 10.1111/j.1399-0004.2010.01472.x.



de Vries AR, te Meerman GJ. A haplotype sharing method for determining the relative age of SNP alleles. Hum Hered. 2010;69(1):52-9. Epub 2009 Oct 2.



Boelens MC, van den Berg A, Fehrmann RS, Geerlings M, de Jong WK, te Meerman GJ, Sietsma H, Timens W, Postma DS, Groen HJ. Current smoking-specific gene expression signature in normal bronchial epithelium is enhanced in squamous cell lung cancer. J Pathol. 2009 Jun;218(2):182-91.



Martens HA, Nolte IM, van der Steege G, Schipper M, Kallenberg CG, Te Meerman GJ, Bijl M. An extensive screen of the HLA region reveals an independent association of HLA class I and class II with susceptibility for systemic lupus erythematosus. Scand J Rheumatol. 2009 Mar 2:1-7.

Crijns AP, Fehrmann RS, de Jong S, Gerbens F, Meersma GJ, Klip HG, Hollema H, Hofstra RM, te Meerman GJ, de Vries EG, van der Zee AG. Survival-related profile, pathways, and transcription factors in ovarian cancer. PLoS Med. 2009 Feb 3;6(2):e24.



Koppelman GH, te Meerman GJ, Postma DS.

Genetic testing for asthma.

Eur Respir J. 2008 Sep;32(3):775-82. Review.

Fehrmann RS, de Jonge HJ, Ter Elst A, de Vries A, Crijns AG, Weidenaar AC,

Gerbens F, de Jong S, van der Zee AG, de Vries EG, Kamps WA, Hofstra RM, Te

Meerman GJ, de Bont ES. A new perspective on transcriptional system regulation (TSR): towards TSR profiling. PLoS ONE. 2008 Feb 20;3(2):e1656.



Niens M, Visser L, Nolte IM, van der Steege G, Diepstra A, Cordano P, Jarrett

RF, Te Meerman GJ, Poppema S, van den Berg A. Serum chemokine levels in Hodgkin lymphoma patients: highly increased levels of CCL17 and CCL22.Br J Haematol. 2008 Mar;140(5):527-36.



Diepstra A, Poppema S, Boot M, Visser L, Nolte IM, Niens M, Te Meerman GJ, van

den Berg A.

HLA-G protein expression as a potential immune escape mechanism in classical

Hodgkin's lymphoma.

Tissue Antigens. 2008 Mar;71(3):219-26.

PMID: 18257895 [PubMed - indexed for MEDLINE]

Fehrmann RS, Li XY, van der Zee AG, de Jong S, Te Meerman GJ, de Vries EG,Crijns AP. Profiling studies in ovarian cancer: a review.

Oncologist. 2007 Aug;12(8):960-6.

Boelens MC, Te Meerman GJ, Gibcus JH, Blokzijl T, Boezen HM, Timens W, Postma DS, Groen HJ, van den Berg A. Microarray amplification bias: loss of 30% differentially expressed genes due to

long probe - poly(A)-tail distances.

BMC Genomics. 2007 Aug 15;8(1):277 [Epub ahead of print]

Niens M, Jarrett RF, Hepkema B, Nolte IM, Diepstra A, Platteel M, Kouprie N,Delury CP, Gallagher A, Visser L, Poppema S, Te Meerman GJ, van den Berg A. HLA-A*02 is associated with a reduced risk and HLA-A*01 with an increased risk of developing EBV-positive Hodgkin lymphoma. Blood. 2007 Jul 13; [Epub ahead of print]

van Tintelen JP, Tio RA, Kerstjens-Frederikse WS, van Berlo JH, Boven LG,Suurmeijer AJ, White SJ, den Dunnen JT, te Meerman GJ, Vos YJ, van der Hout AH,Osinga J, van den Berg MP, van Veldhuisen DJ, Buys CH, Hofstra RM, Pinto YM. Severe myocardial fibrosis caused by a deletion of the 5' end of the lamin A/C gene.J Am Coll Cardiol. 2007 Jun 26;49(25):2430-9. Epub 2007 Jun 11.

Diepstra A, van Imhoff GW, Karim-Kos HE, van den Berg A, te Meerman GJ, Niens M, Nolte IM, Bastiaannet E, Schaapveld M, Vellenga E, Poppema S. HLA class II expression by Hodgkin Reed-Sternberg cells is an independent prognostic factor in classical Hodgkin's lymphoma. J Clin Oncol. 2007 Jul 20;25(21):3101-8. Epub 2007 May 29.

Jabbi M, Kema IP, van der Pompe G, te Meerman GJ, Ormel J, den Boer JA. Catechol-o-methyltransferase polymorphism and susceptibility to major depressive disorder modulates psychological stress response.

Psychiatr Genet. 2007 Jun;17(3):183-93.

Martens HA, Nolte IM, van der Steege G, Schipper M, Kallenberg CG, te Meerman GJ, Bijl M. Association of poly(ADP-ribose) polymerase 1 and a novel candidate locus, LOC127086, with systemic lupus erythematosus. Ann Rheum Dis. 2007 Mar;66(3):424-5. No abstract available.

Szalowska E, Hijum SA, Roelofsen H, Hoek A, Vonk RJ, Meerman GJ. Fractional Factorial Design for Optimization of the SELDI Protocol for Human Adipose Tissue Culture Media.

Biotechnol Prog. 2007 Feb 2;23(1):217-224

Niens M, van den Berg A, Diepstra A, Nolte IM, van der Steege G, Gallagher A, Taylor GM, Jarrett RF, Poppema S, te Meerman GJ. The human leukocyte antigen class i region is associated with EBV-positive Hodgkin's lymphoma: HLA-A and HLA complex group 9 are putative candidate genes. Cancer Epidemiol Biomarkers Prev. 2006 Nov;15(11):2280-4.

Oostenbrug LE, Dijkstra G, Nolte IM, van Dullemen HM, Oosterom E, Faber KN, de Jong DJ, van der Linde K, te Meerman GJ, van der Steege G, Kleibeuker JH,Jansen PL. Absence of association between the multidrug resistance (MDR1) gene and inflammatory bowel disease.

Scand J Gastroenterol. 2006 Oct;41(10):1174-82.

Crijns AP, Gerbens F, Plantinga AE, Meersma GJ, de Jong S, Hofstra RM, de Vries EG, van der Zee AG, de Bock GH, te Meerman GJ.

A biological question and a balanced (orthogonal) design: the ingredients to efficiently analyze two-color microarrays with Confirmatory Factor Analysis. BMC Genomics. 2006 Sep 12;7:232.

ter Elst A, Hiemstra BE, van der Vlies P, Kamminga W, van der Veen AY, Davelaar I, Terpstra P, te Meerman GJ, Gerbens F, Kok K, Buys CH. Functional analysis of lung tumor suppressor activity at 3p21.3. Genes Chromosomes Cancer. 2006 Dec;45(12):1077-93.

Sikkema-Raddatz B, Suijkerbuijk R, van der Vlag J, Stoepker M, Buys CH, te Meerman GJ.

An absolute procedure to test the growth potential of medium and the influence of decreased oxygen tension in primary amniotic fluid cell cultures.Prenat Diagn. 2006 Sep;26(9):855-60.

Sikkema-Raddatz B, Suijkerbuijk R, Bouman K, de Jong B, Buys CH, te Meerman GJ. Quality aspects of prenatal cytogenetic diagnosis: determining the effect of various factors involved in handling amniotic fluid and chorionic villus material for cytogenetic diagnosis. Prenat Diagn. 2006 Sep;26(9):791-800.

Stienstra Y, van der Werf TS, Oosterom E, Nolte IM, van der Graaf WT, Etuaful S, Raghunathan PL, Whitney EA, Ampadu EO, Asamoa K, Klutse EY, Te Meerman GJ, Tappero JW, Ashford DA, van der Steege G. Susceptibility to Buruli ulcer is associated with the SLC11A1 (NRAMP1) D543N

polymorphism. Genes Immun. 2006 Apr;7(3):185-9

Oostenbrug LE, van Dullemen HM, te Meerman GJ, Jansen PL, Kleibeuker JH. Clinical outcome of Crohn's disease according to the Vienna classification: disease location is a useful predictor of disease course. Eur J Gastroenterol Hepatol. 2006 Mar;18(3):255-61.

Kok K, Dijkhuizen T, Swart YE, Zorgdrager H, van der Vlies P, Fehrmann R, te Meerman GJ, Gerssen-Schoorl KB, van Essen T, Sikkema-Raddatz B, Buys CH. Application of a comprehensive subtelomere array in clinical diagnosis of mental retardation. Eur J Med Genet. 2005 Jul-Sep;48(3):250-62.

Zoodsma M, Nolte IM, Schipper M, Oosterom E, van der Steege G, de Vries EG,

te Meerman GJ, van der Zee AG. Analysis of the entire HLA region in susceptibility for cervical cancer: a comprehensive study. J Med Genet. 2005 Aug;42(8):e49.

de Jong MM, Nolte IM, Te Meerman GJ, van der Graaf WT, Oosterom E,

Bruinenberg M, Steege G, Oosterwijk JC, van der Hout AH, Boezen HM, Schaapveld

M, Kleibeuker JH, de Vries EG.

No increased susceptibility to breast cancer from combined CHEK2 1100delC

genotype and the HLA class III region risk factors.

Eur J Cancer. 2005 Aug;41(12):1819-23.



Diepstra A, Niens M, te Meerman GJ, Poppema S, van den Berg A.

Genetic susceptibility to Hodgkin's lymphoma associated with the human

leukocyte antigen region.

Eur J Haematol Suppl. 2005 Jul;(66):34-41. Review.



Diepstra A, Niens M, Vellenga E, van Imhoff GW, Nolte IM, Schaapveld M, van

der Steege G, van den Berg A, Kibbelaar RE, te Meerman GJ, Poppema S.

Association with HLA class I in Epstein-Barr-virus-positive and with HLA class

III in Epstein-Barr-virus-negative Hodgkin's lymphoma.

Lancet. 2005 Jun 25-Jul 1;365(9478):2216-24.



Oostenbrug LE, Drenth JP, de Jong DJ, Nolte IM, Oosterom E, van Dullemen HM,

van der Linde K, te Meerman GJ, van der Steege G, Kleibeuker JH, Jansen PL.

Association between Toll-like receptor 4 and inflammatory bowel disease.

Inflamm Bowel Dis. 2005 Jun;11(6):567-75.



de Jong MM, Nolte IM, Te Meerman GJ, van der Graaf WT, Mulder MJ, van der

Steege G, Bruinenberg M, Schaapveld M, Niessen RC, Berends MJ, Sijmons RH,

Hofstra RM, de Vries EG, Kleibeuker JH.

Colorectal cancer and the CHEK2 1100delC mutation.

Genes Chromosomes Cancer. 2005 Aug;43(4):377-82.



Niens M, Spijker GT, Diepstra A, Te Meerman GJ.

A factorial experiment for optimizing the PCR conditions in routine genotyping:

optimizing PCR conditions.

Biotechnol Appl Biochem. 2005 Apr 25; [Epub ahead of print]



Jongepier H, Koppelman GH, Nolte IM, Bruinenberg M, Bleecker ER, Meyers DA,

te Meerman GJ, Postma DS.

Polymorphisms in SPINK5 are not associated with asthma in a Dutch population.

J Allergy Clin Immunol. 2005 Mar;115(3):486-92.





de Jong MM, Niens M, Nolte IM, te Meerman GJ, van der Graaf WT, Mulder MJ,

van der Steege G, Bruinenberg M, Schaapveld M, Sijmons RH, Hofstra RM, de Vries

EG, Kleibeuker JH.

The human leukocyte antigen region and colorectal cancer risk.

Dis Colon Rectum. 2005 Feb;48(2):303-6.



Zoodsma M, Nolte IM, Te Meerman GJ, De Vries EG, Van der Zee AG.

HLA genes and other candidate genes involved in susceptibility for

(pre)neoplastic cervical disease.

Int J Oncol. 2005 Mar;26(3):769-84. Review.



Donker RB, Asgeirsdottir SA, Gerbens F, van Pampus MG, Kallenberg CG, te

Meerman GJ, Aarnoudse JG, Molema G.

Plasma factors in severe early-onset preeclampsia do not substantially alter

endothelial gene expression in vitro.

J Soc Gynecol Investig. 2005 Feb;12(2):98-106.



Foerster J, Nolte I, Junge J, Bruinenberg M, Schweiger S, Spaar K, van der

Steege G, Ehlert C, Mulder M, Kalscheuer V, Blumenthal-Barby E, Winter J, Seeman

P, Stander M, Sterry W, Te Meerman G.

Haplotype sharing analysis identifies a retroviral dUTPase as candidate

susceptibility gene for psoriasis.

J Invest Dermatol. 2005 Jan;124(1):99-102.



de Jong MM, te Meerman GJ, van der Graaf WT, de Vries EG, Nolte IM, Mulder

MJ, Bruinenberg M, van der Steege G, Schaapveld M, Sijmons RH, Hofstra RM,

Kleibeuker JH.

No association between the Arg201Gly polymorphism of the DCC gene and

colorectal cancer.

Dig Liver Dis. 2004 Dec;36(12):821-3.





Spijker GT, Bruinenberg M, Te Meerman GJ.

Efficiency control in large-scale genotyping using analysis of variance.

Appl Biochem Biotechnol. 2005 Jan;120(1):29-36.



Spijker GT, Nolte IM, Jansen RC, Te Meerman GJ.

Genetic association studies in complex disease: disentangling additional

predisposing Loci from associated neutral Loci using a constrained - permutation

approach.

Ann Hum Genet. 2005 Jan;69(Pt 1):90-101.





Zoodsma M, Nolte IM, Schipper M, Oosterom E, van der Steege G, de Vries EG,

Te Meerman GJ, van der Zee AG.

Methylenetetrahydrofolate reductase (MTHFR) and susceptibility for

(pre)neoplastic cervical disease.

Hum Genet. 2005 Jan 6; [Epub ahead of print]



Boon M, Nolte IM, De Keyser J, Buys CH, te Meerman GJ.

Inheritance mode of multiple sclerosis: the effect of HLA class II alleles is

stronger than additive.

Hum Genet. 2004 Sep;115(4):280-4.





de Jong MM, Hofstra RM, Kooi KA, Westra JL, Berends MJ, Wu Y, Hollema H, van

der Sluis T, van der Graaf WT, de Vries EG, Schaapveld M, Sijmons RH, te Meerman

GJ, Kleibeuker JH.

No association between two MLH3 variants (S845G and P844L)and colorectal cancer

risk.

Cancer Genet Cytogenet. 2004 Jul 1;152(1):70-1.







Foerster J, Nolte I, Schweiger S, Ehlert C, Bruinenberg M, Spaar K, van der

Steege G, Mulder M, Kalscheuer V, Moser B, Kijas Z, Seeman P, Stander M, Sterry

W, te Meerman G.

Evaluation of the IRF-2 gene as a candidate for PSORS3.

J Invest Dermatol. 2004 Jan;122(1):61-4.





Oostenbrug LE, van Dullemen HM, te Meerman GJ, Jansen PL.

IBD and genetics: new developments.

Scand J Gastroenterol Suppl. 2003;(239):63-8.





Trentani A, Kuipers SD, te Meerman GJ, Beekman J, ter Horst GJ, den Boer JA.

Immunohistochemical changes induced by repeated footshock stress: revelations

of gender-based differences.

Neurobiol Dis. 2003 Dec;14(3):602-18.



de Jong MM, Nolte IM, de Vries EG, Schaapveld M, Kleibeuker JH, Oosterom E,

Oosterwijk JC, van der Hout AH, van der Steege G, Bruinenberg M, Boezen HM, Te

Meerman GJ, van der Graaf WT.

The HLA class III subregion is responsible for an increased breast cancer risk.

Hum Mol Genet. 2003 Sep 15;12(18):2311-9. Epub 2003 Jul 22.





Fischer C, Beckmann L, Majoram P, te Meerman G, Chang-Claude J.

Haplotype sharing analysis with SNPs in candidate genes: the Genetic Analysis

Workshop 12 example.

Genet Epidemiol. 2003 Jan;24(1):68-73.





de Jong MM, Nolte IM, te Meerman GJ, van der Graaf WT, de Vries EG, Sijmons

RH, Hofstra RM, Kleibeuker JH.

Low-penetrance genes and their involvement in colorectal cancer susceptibility.

Cancer Epidemiol Biomarkers Prev. 2002 Nov;11(11):1332-52. Review.





Sonneveld DJ, Lutke Holzik MF, Nolte IM, Sleijfer DT, van der Graaf WT,

Bruinenberg M, Sijmons RH, Hoekstra HJ, Te Meerman GJ.

Testicular carcinoma and HLA Class II genes.

Cancer. 2002 Nov 1;95(9):1857-63.





Nolte IM, Te Meerman GJ.

The probability that similar haplotypes are identical by descent.

Ann Hum Genet. 2002 May;66(Pt 3):195-209.



Maugeri A, Flothmann K, Hemmrich N, Ingvast S, Jorge P, Paloma E, Patel R,

Rozet JM, Tammur J, Testa F, Balcells S, Bird AC, Brunner HG, Hoyng CB, Metspalu

A, Simonelli F, Allikmets R, Bhattacharya SS, D'Urso M, Gonzalez-Duarte R,

Kaplan J, te Meerman GJ, Santos R, Schwartz M, Van Camp G, Wadelius C, Weber BH,

Cremers FP.

The ABCA4 2588G>C Stargardt mutation: single origin and increasing frequency

from South-West to North-East Europe.

Eur J Hum Genet. 2002 Mar;10(3):197-203.



de Jong MM, Nolte IM, te Meerman GJ, van der Graaf WT, Oosterwijk JC,

Kleibeuker JH, Schaapveld M, de Vries EG.

Genes other than BRCA1 and BRCA2 involved in breast cancer susceptibility.

J Med Genet. 2002 Apr;39(4):225-42. Review.





Sikkema-Raddatz B, van Echten J, van der Vlag J, Buys CH, te Meerman GJ.

Minimal volume of amniotic fluid for reliable prenatal cytogenetic diagnosis.

Prenat Diagn. 2002 Feb;22(2):164-5. No abstract available.





Beckmann L, Fischer C, Deck KG, Nolte IM, te Meerman G, Chang-Claude J.

Exploring haplotype sharing methods in general and isolated populations to

detect gene(s) of a complex genetic trait.

Genet Epidemiol. 2001;21 Suppl 1:S554-9.





Levinson DF, Nolte I, te Meerman GJ.

Haplotype sharing tests of linkage disequilibrium in a Hutterite asthma data

set.

Genet Epidemiol. 2001;21 Suppl 1:S308-11.





Boon M, Nolte IM, Bruinenberg M, Spijker GT, Terpstra P, Raelson J, De

Keyser J, Zwanikken CP, Hulsbeek M, Hofstra RM, Buys CH, te Meerman GJ.

Mapping of a susceptibility gene for multiple sclerosis to the 51 kb interval

between G511525 and D6S1666 using a new method of haplotype sharing analysis.

Neurogenetics. 2001 Oct;3(4):221-30.





Lutke Holzik MF, Sonneveld DJ, Hoekstra HJ, te Meerman GJ, Sleijfer DT,

Schaapveld M.

Do the eastern and northern parts of The Netherlands differ in testicular

cancer?

Urology. 2001 Oct;58(4):636-7. No abstract available.





Links TP, van Tol KM, Meerman GJ, de Vries EG.

Differentiated thyroid carcinoma: a polygenic disease.

Thyroid. 2001 Dec;11(12):1135-40. Review.







te Meerman GJ, de Vries EG.

Relevance of high and low penetrance.

Lancet. 2001 Jul 28;358(9278):331-2. No abstract available.





Stienstra Y, van der Graaf WT, te Meerman GJ, The TH, de Leij LF, van der

Werf TS.

Susceptibility to development of Mycobacterium ulcerans disease: review of

possible risk factors.

Trop Med Int Health. 2001 Jul;6(7):554-62. Review.



Levinson DF, Kirby A, Slepner S, Nolte I, Spijker GT, te Meerman G.

Simulation studies of detection of a complex disease in a partially isolated

population.

Am J Med Genet. 2001 Jan 8;105(1):65-70.





Molenaar WM, Plaat BE, Berends ER, te Meerman GJ.

Observer reliability in assessment of mitotic activity and MIB-1-determined

proliferation rate in pediatric sarcomas.

Ann Diagn Pathol. 2000 Aug;4(4):228-35.



van Munster EB, Stap J, Hoebe RA, te Meerman GJ, Aten JA.

Difference in sperm head volume as a theoretical basis for sorting X- and

Y-bearing spermatozoa: potentials and limitations.

Theriogenology. 1999 Dec;52(8):1281-93.



van Munster EB, Stap J, Hoebe RA, te Meerman GJ, Aten JA.

Difference in volume of X- and Y-chromosome-bearing bovine sperm heads matches

difference in DNA content.

Cytometry. 1999 Feb 1;35(2):125-8.





Sonneveld DJ, Schaapveld M, Sleijfer DT, Meerman GJ, van der Graaf WT,

Sijmons RH, Koops HS, Hoekstra HJ. Geographic clustering of testicular cancer incidence in the northern part of The Netherlands. Br J Cancer. 1999 Dec;81(7):1262-7.





Plaat BE, Molenaar WM, Mastik MF, Hoekstra HJ, te Meerman GJ, van den Berg

E.

Computer-assisted cytogenetic analysis of 51 malignant peripheral-nerve-sheath

tumors: sporadic vs. neurofibromatosis-type-1-associated malignant schwannomas.

Int J Cancer. 1999 Oct 8;83(2):171-8.





Dorum A, Moller P, Kamsteeg EJ, Scheffer H, Burton M, Heimdal KR, Maehle

LO, Hovig E, Trope CG, van der Hout AH, van der Meulen MA, Buys CH, te Meerman

GJ.

A BRCA1 founder mutation, identified with haplotype analysis, allowing

genotype/phenotype determination and predictive testing.

Eur J Cancer. 1997 Dec;33(14):2390-2.





Tuerlings JH, Mol B, Kremer JA, Looman M, Meuleman EJ, te Meerman GJ, Buys

CH, Merkus HM, Scheffer H.

Mutation frequency of cystic fibrosis transmembrane regulator is not increased

in oligozoospermic male candidates for intracytoplasmic sperm injection.

Fertil Steril. 1998 May;69(5):899-903.



te Meerman GJ, Van der Meulen MA.

Genomic sharing surrounding alleles identical by descent: effects of genetic

drift and population growth.

Genet Epidemiol. 1997;14(6):1125-30.



Van der Meulen MA, te Meerman GJ.

Haplotype sharing analysis in affected individuals from nuclear families with

at least one affected offspring.

Genet Epidemiol. 1997;14(6):915-20.



van Echten J, van der Vloedt WS, van de Pol M, Dam A, te Meerman GJ,

Schraffordt Koops H, Sleijfer DT, Oosterhuis JW, de Jong B.

Comparison of the chromosomal pattern of primary testicular nonseminomas and

residual mature teratomas after chemotherapy.

Cancer Genet Cytogenet. 1997 Nov;99(1):59-67.





Dankert-Roelse JE, te Meerman GJ.

Screening for cystic fibrosis--time to change our position?

N Engl J Med. 1997 Oct 2;337(14):997-9. No abstract available.





Scheffer H, Stulp RP, Verlind E, van der Meulen M, Bruckner-Tuderman L,

Gedde-Dahl T Jr, te Meerman GJ, Sonnenberg A, Buys CH, Jonkman MF.

Implications of intragenic marker homozygosity and haplotype sharing in a rare

autosomal recessive disorder: the example of the collagen type XVII (COL17A1)

locus in generalised atrophic benign epidermolysis bullosa.

Hum Genet. 1997 Aug;100(2):230-5.





Sikkema-Raddatz B, Castedo S, Te Meerman GJ.

Probability tables for exclusion of mosaicism in prenatal diagnosis.

Prenat Diagn. 1997 Feb;17(2):115-8.





de Vries HG, van der Meulen MA, Rozen R, Halley DJ, Scheffer H, ten Kate

LP, Buys CH, te Meerman GJ.

Haplotype identity between individuals who share a CFTR mutation allele

"identical by descent": demonstration of the usefulness of the haplotype-sharing

concept for gene mapping in real populations.

Hum Genet. 1996 Sep;98(3):304-9.





Te Meerman GJ, Van der Meulen MA, Sandkuijl LA.

Perspectives of identity by descent (IBD) mapping in founder populations.

Clin Exp Allergy. 1995 Nov;25 Suppl 2:97-102.





Mullaart E, Verwest AM, Borglum AD, Uitterlinden AG, te Meerman GJ, Kruse

TA, Vijg J.

Two-dimensional DNA typing of human pedigrees: spot pattern characterization

and segregation.

Genomics. 1995 Oct 10;29(3):641-6.



van Echten J, Oosterhuis JW, Looijenga LH, van de Pol M, Wiersema J, te

Meerman GJ, Schaffordt Koops H, Sleijfer DT, de Jong B.

No recurrent structural abnormalities apart from i(12p) in primary germ cell

tumors of the adult testis.

Genes Chromosomes Cancer. 1995 Oct;14(2):133-44.



Dankert-Roelse JE, te Meerman GJ.

Long term prognosis of patients with cystic fibrosis in relation to early

detection by neonatal screening and treatment in a cystic fibrosis centre.

Thorax. 1995 Jul;50(7):712-8.



van der Meulen MA, van der Meulen MJ, te Meerman GJ.

Recurrence risk for germinal mosaics revisited.

J Med Genet. 1995 Feb;32(2):102-4.



te Meerman GJ, Mullaart E, van der Meulen MA, den Daas JH, Morolli B,

Uitterlinden AG, Vijg J.

Linkage analysis by two-dimensional DNA typing.

Am J Hum Genet. 1993 Dec;53(6):1289-97.

PMID: 8250045



de Graaff WE, van Echten-Arends J, Oosterhuis JW, de Jong B, te Meerman GJ,

Wiersema-Buist J, Sleijfer DT, Schraffordt Koops H.

Cytogenetic abnormalities and clinical stage in testicular nonseminomatous germ

cell tumors.

Cancer Genet Cytogenet. 1993 Oct 1;70(1):12-6.



Mullaart E, de Vos GJ, te Meerman GJ, Uitterlinden AG, Vijg J.

Parallel genome analysis by two-dimensional DNA typing.

Nature. 1993 Sep 30;365(6445):469-71.





Cornel MC, Breed AS, Beekhuis JR, te Meerman GJ, ten Kate LP.

Down syndrome: effects of demographic factors and prenatal diagnosis on the

future livebirth prevalence.

Hum Genet. 1993 Sep;92(2):163-8.





van Leeuwen MA, van Rijswijk MH, van der Heijde DM, Te Meerman GJ, van Riel

PL, Houtman PM, van De Putte LB, Limburg PC.

The acute-phase response in relation to radiographic progression in early

rheumatoid arthritis: a prospective study during the first three years of the

disease.

Br J Rheumatol. 1993 Jun;32 Suppl 3:9-13.





Menko FH, te Meerman GJ, Sampson JR.

Variable age of onset in hereditary nonpolyposis colorectal cancer: clinical

implications.

Gastroenterology. 1993 Mar;104(3):946-7. No abstract available.





Landsvater RM, Rombouts AG, te Meerman GJ, Schillhorn-van Veen JM, Berends

MJ, Geerdink RA, Struyvenberg A, Buys CH, Lips CJ.

The clinical implications of a positive calcitonin test for C-cell hyperplasia

in genetically unaffected members of an MEN2A kindred.

Am J Hum Genet. 1993 Feb;52(2):335-42.





Scheffer H, Houwen RH, Te Meerman GJ, Loessner J, Bachmann B, Kunert E,

Verlind E, Buys CH.

Identification of crossovers in Wilson disease families as reference points for

a genetic localization of the gene.

Hum Genet. 1992 Aug;89(6):607-11.





van Essen AJ, Busch HF, te Meerman GJ, ten Kate LP.

Birth and population prevalence of Duchenne muscular dystrophy in The

Netherlands.

Hum Genet. 1992 Jan;88(3):258-66.





Swaving J, Groenewegen A, Kamstra A, te Meerman GJ, ten Kate LP.

Family distances as a measure of hidden consanguinity. A reappraisal.

Hum Hered. 1991;41(1):12-6.





te Meerman GJ, Dankert-Roelse JE.

Pros and cons of neonatal screening for cystic fibrosis.

Adv Exp Med Biol. 1991;290:83-92; discussion 92-5. No abstract available.



Houwen RH, Scheffer H, te Meerman GJ, van der Vlies P, Buys CH.

Close linkage of the Wilson's disease locus to D13S12 in the chromosomal region

13q21 and not to ESD in 13q14.

Hum Genet. 1990 Oct;85(5):560-2.





Cornel MC, ten Kate LP, te Meerman GJ.

Association between ovulation stimulation, in vitro fertilisation, and neural

tube defects?

Teratology. 1990 Sep;42(3):201-3. No abstract available.





Scheffer H, Bruinvels DJ, te Meerman GJ, Verlind E, Penninga D, Dankert J,

Ten Kate LP, Buys CH.

Frequency of the delta F508 mutation and XV2c,KM19 haplotypes in cystic

fibrosis families from The Netherlands: haplotypes without delta F508 still in

disequilibrium.

Hum Genet. 1990 Sep;85(4):425-7.



de Jong B, Oosterhuis JW, Castedo SM, Vos A, te Meerman GJ.

Pathogenesis of adult testicular germ cell tumors. A cytogenetic model.

Cancer Genet Cytogenet. 1990 Sep;48(2):143-67. Review.

PMID: 2168805



Cornel MC, de Jong-van den Berg LT, Koudstaal J, Wiegerinck MA, te Meerman

GJ, ten Kate LP.

[Indications for an increased risk of neural tube defects in pregnancies

following ovulation induction and (or) in-vitro fertilization]

Ned Tijdschr Geneeskd. 1990 Jul 14;134(28):1357-61. Dutch.





63: van den Berg-de Ruiter E, de Jong B, Mulder NH, te Meerman GJ, Schraffordt

Koops H, Sleijfer DT.

Chromosomal damage in peripheral blood lymphocytes of patients treated for

testicular cancer.

Hum Genet. 1990 Jan;84(2):191-4.

PMID: 2298456



Cornel MC, Ten Kate LP, Te Meerman GJ.

Ovulation induction, in-vitro fertilisation, and neural tube defects.

Lancet. 1989 Dec 23-30;2(8678-8679):1530. Review. No abstract available.





Castedo SM, de Jong B, Oosterhuis JW, Seruca R, Idenburg VJ, Dam A, te

Meerman G, Koops HS, Sleijfer DT.

Chromosomal changes in human primary testicular nonseminomatous germ cell

tumors.

Cancer Res. 1989 Oct 15;49(20):5696-701.





Maciejko D, Bal J, Mazurczak T, te Meerman G, Buys C, Oostra B, Halley D.

Different haplotypes for cystic fibrosis-linked DNA polymorphisms in Polish and

Dutch populations.

Hum Genet. 1989 Oct;83(3):220-2.





Scheffer H, te Meerman GJ, Kruize YC, van den Berg AH, Penninga DP, Tan KE,

der Kinderen DJ, Buys CH.

Linkage analysis of families with hereditary retinoblastoma: nonpenetrance of

mutation, revealed by combined use of markers within and flanking the RB1 gene.

Am J Hum Genet. 1989 Aug;45(2):252-60. Erratum in: Am J Hum Genet 1989

Dec;45(6):983.





Landsvater RM, Mathew CG, Smith BA, Marcus EM, te Meerman GJ, Lips CJ,

Geerdink RA, Nakamura Y, Ponder BA, Buys CH.

Development of multiple endocrine neoplasia type 2A does not involve

substantial deletions of chromosome 10.

Genomics. 1989 Apr;4(3):246-50.





te Meerman GJ, Buys CH.

Remarks on the article "Use of Linkage Equilibrium Data in Prenatal Diagnosis

of Cystic Fibrosis" by L. Strain et al.

Hum Genet. 1989 Apr;82(1):96-7. No abstract available.





Dankert-Roelse JE, te Meerman GJ, Martijn A, ten Kate LP, Knol K.

Survival and clinical outcome in patients with cystic fibrosis, with or without

neonatal screening.

J Pediatr. 1989 Mar;114(3):362-7.





Castedo SM, de Jong B, Oosterhuis JW, Idenburg VJ, Seruca R, Buist J, te

Meerman GJ, Schraffordt Koops H, Sleijfer DT.

Chromosomal changes in mature residual teratomas following polychemotherapy.

Cancer Res. 1989 Feb 1;49(3):672-6.





Castedo SM, de Jong B, Oosterhuis JW, Seruca R, te Meerman GJ, Dam A,

Schraffordt Koops H.

Cytogenetic analysis of ten human seminomas.

Cancer Res. 1989 Jan 15;49(2):439-43.





ten Kate LP, te Meerman GJ, Buys CH.

Effectiveness of prevention of cystic fibrosis by artificial insemination by

donor can be markedly improved by DNA-analysis of sperm donors.

Am J Med Genet. 1989 Jan;32(1):148-9. No abstract available.



te Meerman GJ, ten Kate LP, Buys CC.

Prenatal diagnosis of cystic fibrosis.

Lancet. 1988 Dec 3;2(8623):1319. No abstract available.



te Meerman GI, ten Kate LP, Cobben JM, von Essen T, Buys CH, Halley D.

Prenatal diagnosis of cystic fibrosis where single affected child has died.

Lancet. 1988 Sep 24;2(8613):745. No abstract available.





Ten Kate LP, Dolk H, Cornel MC, De Wals P, Te Meerman GJ, Lechat MF,

Weatherall JA.

Frequency of births with potentially avoidable serious chromosomal anomalies in

EEC countries, 1979-1982.

J Epidemiol Community Health. 1988 Sep;42(3):266-70.





Dankert-Roelse JE, te Meerman GJ, Knol K, ten Kate LP.

Effect of screening for cystic fibrosis on the influence of genetic counseling.

Clin Genet. 1987 Oct;32(4):271-5.





Dankert-Roelse JE, te Meerman GJ, Martijn A, ten Kate LP, Knol K.

Screening for cystic fibrosis. A comparative study.

Acta Paediatr Scand. 1987 Mar;76(2):209-14.





te Meerman GJ, Karel ER, ten Kate LP.

Ascertainment bias and power of procedures to estimate differences between male

and female mutation rates.

Hum Genet. 1987 Mar;75(3):296-7. No abstract available.





Nauta MJ, van Treuren R, ten Kate LP, te Meerman GJ, D'Amaro J.

Family distances and human lymphocyte antigens.

Hum Hered. 1987;37(6):359-64.





Cornel MC, Swagemakers ML, te Meerman GJ, Haayer EJ, ten Kate LP.

[EUROCAT registration of congenital abnormalities and multiple births; aims,

methods and results of the Dutch share of the project 1981-1983]

Ned Tijdschr Geneeskd. 1986 Jul 5;130(27):1233-7. Dutch. No abstract available.





Dankert-Roelse JE, Meerman GJ, Cornel MC, Knol K, ten Kate LP.

Neonatal screening for cystic fibrosis.

Lancet. 1986 Apr 5;1(8484):802-3. No abstract available.





Karel ER, te Meerman GJ, Ten Kate LP.

On the power to detect differences between male and female mutation rates for

Duchenne muscular dystrophy, using classical segregation analysis and

restriction fragment length polymorphisms.

Am J Hum Genet. 1986 Jun;38(6):827-40. Erratum in: Am J Hum Genet 1987

Aug;41(2):330.





Lanting PJ, Borsboom PC, te Meerman GJ, ten Kate LP.

Decreased scattering coefficient of blue sclerae.

Clin Genet. 1985 Feb;27(2):187-90.





te Meerman GJ, Dankert-Roelse J, Martijn A, van Woerden HH.

A comparison of the Shwachman, Chrispin-Norman and Brasfield methods for

scoring of chest radiographs of patients with cystic fibrosis.

Pediatr Radiol. 1985;15(2):98-101.





ten Kate LP, te Meerman GJ, Anders GJ.

Risk of Down's syndrome among second- and third-degree relatives of a proband

with trisomy 21.

Am J Med Genet. 1984 Nov;19(3):599-602. No abstract available.  

Laatst gewijzigd:13 februari 2020 16:25

Contact information

Antonius Deusinglaan 1
9713 AV Groningen
The Netherlands

ingang oostersingel

Job title:
investigator retired associate professor
Working hours:
tussen 10.30 en 14.50

Home address

Klooslaan 12
9721XN
 
Groningen